North Star Investment Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-43,000
Closed -$8.99K 1278
2024
Q3
$8.99K Hold
43,000
﹤0.01% 860
2024
Q2
$9.93K Hold
43,000
﹤0.01% 816
2024
Q1
$37K Buy
43,000
+12,000
+39% +$8.22K ﹤0.01% 655
2023
Q4
$12.1K Hold
31,000
﹤0.01% 792
2023
Q3
$49.6K Hold
31,000
﹤0.01% 591
2023
Q2
$90.5K Buy
31,000
+5,000
+19% +$11.3K 0.01% 518
2023
Q1
$62.9K Hold
26,000
0.01% 588
2022
Q4
$48.6K Buy
26,000
+8,000
+44% +$12.5K ﹤0.01% 597
2022
Q3
$23K Buy
18,000
+13,000
+260% +$28.3K ﹤0.01% 676
2022
Q2
$12K Hold
5,000
﹤0.01% 794
2022
Q1
$35K Buy
+5,000
New +$53K ﹤0.01% 657

Other funds holding RNLX

North Star Investment Management's RNLX Position: Q4 2024 in Review

North Star Investment Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 43,000 shares — an estimated $8.99K sold.

North Star Investment Management first reported a position in RNLX in Q1 2022 and held it in 11 quarters. The position peaked at $90.5K in Q2 2023. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • North Star Investment Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • North Star Investment Management sold 43,000 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $8.99K.
  • North Star Investment Management first reported a position in Renalytix plc American Depositary Shares in Q1 2022 and held it in 11 quarters.
  • North Star Investment Management's Renalytix plc American Depositary Shares position peaked at $90.5K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on North Star Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.